Urinary Soluble CD163: A Novel Biomarker Suggests Who Should Receive Glucocorticoids in IgA Nephropathy
Saved in:
| Main Authors: | Guisen Li, Susan J. Thanabalasingam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-10-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924018837 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IgA Nephropathy in the Elderly
by: Dana V. Rizk, et al.
Published: (2025-08-01) -
Corrigendum to “Is childhood IgA nephropathy different from adult IgA nephropathy? A narrative review”
Published: (2025-07-01) -
A study on correlation of measures of urinary protein and albumin with progression of IgA nephropathy
by: ZHANG Xue-jing, et al.
Published: (2019-01-01) -
Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
by: Mototsugu Tanaka, et al.
Published: (2011-01-01) -
Soluble CD206 and CD163 as novel prognostic biomarkers in adult acute myeloid leukemia
by: Haifa A. Al-Matari, et al.
Published: (2024-11-01)